Drug Database
Back to search

Netherlands· NL-b410b8a4f20a

Attrogy 250 mg filmomhulde tabletten

A diflunisal product containing diflunisal, registered in Netherlands by AO Pharma AB. The same ATC class is registered in 10 of our 19 countries.

ATC N02BA11

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedAttrogy 250 mg filmomhulde tablettenATCN02BA11REGISTER NO.NL-b410b8a4f20aPACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about diflunisalAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Diflunisal is registered in 10 of 19 countries.

Countries holding a registration under ATC N02BA11 (diflunisal), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose
Search diflunisal products by name

Diflunisal · ATC N02BA11

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Spainprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
DIFLUNISAL
Manufacturer
AO Pharma AB
Country
Netherlands (NL)
ATC code
N02BA11
ATC class
Diflunisal
Defined daily dose
0.75 g, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/25/1929

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

227 interactions on record for diflunisal.

Graded by severity as the source publishes them — 57 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check diflunisal against other medicinesHow interaction checks work

Diflunisal · interactions on record

227 records

  • 57 severe
  • 144 moderate
  • 10 minor
  • 16 info

Most severe, free to view

  • DicoumarolB01AA01severe
  • WarfarinB01AA03severe
  • DalteparinB01AB04severe
  • EnoxaparinB01AB05severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Diflunisal in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All diflunisal products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fe48210b-cb99-4d12-a454-a7b37764a58c
GET /v1/drugs/fe48210b-cb99-4d12-a454-a7b37764a58c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/attrogy-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Diflunisal",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp132898",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "MACROGOL 3350",
    "MAGNESIUMSTEARAAT (E 470b)",
    "SILICIUMDIOXIDE (E 551)",
    "TITAANDIOXIDE (E 171)",
    "ZETMEEL, GEPREGELATINEERD",
    "ZONNEGEEL FCF ALUMINIUMLAK (E 110)"
  ],
  "substances": [
    "DIFLUNISAL"
  ],
  "leaflet_url": null,
  "authorised_at": "2025/07/17",
  "procedure_number": "EMEA/H/C/006248",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/25/1929",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about diflunisal.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console